NAVCO PHARMACEUTICALS INC (NAV.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:NAV - CA63942R1091 - Common Stock
NAV.CA Key Statistics, Chart & Performance
The current stock price of NAV.CA is 0.005 CAD. In the past year, price decreased by -85.71%.
About NAV.CA
Company Profile
Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-05. The firm is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. The company manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The firm's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. The company offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. The company also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
Company Info
NAVCO PHARMACEUTICALS INC
Suite 1500, 1055 West Georgia Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16043078290
NAVCO PHARMACEUTICALS INC / NAV.CA FAQ
What does NAVCO PHARMACEUTICALS INC do?
Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-05. The firm is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. The company manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The firm's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. The company offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. The company also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
Can you provide the latest stock price for NAVCO PHARMACEUTICALS INC?
The current stock price of NAV.CA is 0.005 CAD. The price decreased by -50% in the last trading session.
Does NAV stock pay dividends?
NAV.CA does not pay a dividend.
How is the ChartMill rating for NAVCO PHARMACEUTICALS INC?
NAV.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the PE ratio for NAV stock?
NAVCO PHARMACEUTICALS INC (NAV.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
What is the employee count for NAV stock?
NAVCO PHARMACEUTICALS INC (NAV.CA) currently has 0 employees.
NAV.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NAV.CA. When comparing the yearly performance of all stocks, NAV.CA is a bad performer in the overall market: 97.52% of all stocks are doing better.
NAV.CA Financial Highlights
Over the last trailing twelve months NAV.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -419.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13676.12% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |